{"database": "lobbying", "table": "lobbying_activities", "rows": [[1689568, "841047b9-c46b-4a4b-8500-dcfa61a3e62c", "2T", "ANGELA STEWART", 401103673, "EISAI, INC", 2015, "second_quarter", "PHA", "DEA scheduling of controlled substances\nImproving Regulatory Transparency for New Medical Therapies Act (H.R. 639/S. 481)", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 1, "2015-06-11T16:00:20.950000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1689568"], "units": {}, "query_ms": 26.063779019750655, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}